Literature DB >> 10672127

Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity.

G Berglund1, P Nilsson, K F Eriksson, J A Nilsson, B Hedblad, H Kristenson, F Lindgärde.   

Abstract

OBJECTIVES: To analyse the effects on mortality and cardiovascular morbidity in a population-based sample, invited to an intervention programme incorporating a baseline screening examination and treatment programmes for subjects with cardiovascular risk factors, high alcohol intake and, in women, suspicion of breast cancer on mammography.
SETTING: Section of Preventive Medicine, Department of Medicine, University Hospital, Malmö, Sweden.
SUBJECTS: Birth cohorts (aged 32-51 years) invited to screening examination (men = 9. 923; women = 4.422) were compared to birth cohorts not invited (men = 6.655; women = 4.290). Mean participation rate in the invited cohorts was 71% (range 64-78%). SCREENING EXAMINATION: Between 1974 and 1992 a baseline screening including a physical examination, blood pressure, a questionnaire regarding, e.g. family history, lifestyle, and socio-economic factors, laboratory tests of serum cholesterol, triglycerides, gamma-glutamyl-transferase, blood glucose before and after an oral glucose load, as well as a mammography examination in women, was performed.
INTERVENTIONS: Subjects with hypertension; hyperlipidaemia; diabetes or glucose intolerance; high alcohol intake; or, in women, suspicion of breast cancer were referred to special outpatient clinics. MAIN OUTCOME MEASURES: Total and cause-specific mortality, nonfatal myocardial infarction, and stroke, from the screening examination until the end of 1995, was followed in both the intervention and control groups, using national and/or local registries.
RESULTS: Total mortality did not differ significantly between the intervention group and control group. Cause-specific deaths were also similar except for 'other' deaths amongst men being significantly lower in the intervention group, mainly due to a lower mortality from 'other' causes (suicide, alcohol related deaths) in men under 40 years of age at baseline. Women under 40 years of age had a significantly lower mortality from cancer in the intervention group than in the control group. Nonfatal myocardial infarction and stroke did not differ between intervention and control group in either sex. Within the invited birth cohorts, nonparticipants had a higher total and cause-specific mortality.
CONCLUSIONS: Risk factor screening for major diseases such as cardiovascular disease, alcohol abuse, diabetes mellitus and breast cancer, and subsequent treatment of the detected risk factors/diseases - The Malmö Preventive Project - did not reduce total mortality in the intervention group as a whole. In subjects under 40 years of age at entry, total mortality was lower in the intervention group than in the control group. In men, this seemed to be due to a reduction of alcohol-related deaths, whilst in women death from cancer was reduced.

Entities:  

Mesh:

Year:  2000        PMID: 10672127     DOI: 10.1046/j.1365-2796.2000.00568.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  64 in total

1.  Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.

Authors:  Valeriya Lyssenko; Roberto Lupi; Piero Marchetti; Silvia Del Guerra; Marju Orho-Melander; Peter Almgren; Marketa Sjögren; Charlotte Ling; Karl-Fredrik Eriksson; Asa-Linda Lethagen; Rita Mancarella; Göran Berglund; Tiinamaija Tuomi; Peter Nilsson; Stefano Del Prato; Leif Groop
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults.

Authors:  A Jonsson; F Renström; V Lyssenko; E C Brito; B Isomaa; G Berglund; P M Nilsson; L Groop; P W Franks
Journal:  Diabetologia       Date:  2009-04-17       Impact factor: 10.122

3.  Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts.

Authors:  Tanja Stocks; Kilian Rapp; Tone Bjørge; Jonas Manjer; Hanno Ulmer; Randi Selmer; Annekatrin Lukanova; Dorthe Johansen; Hans Concin; Steinar Tretli; Göran Hallmans; Håkan Jonsson; Pär Stattin
Journal:  PLoS Med       Date:  2009-12-22       Impact factor: 11.069

4.  Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes.

Authors:  Jason Flannick; Nicola L Beer; Alexander G Bick; Vineeta Agarwala; Janne Molnes; Namrata Gupta; Noël P Burtt; Jose C Florez; James B Meigs; Herman Taylor; Valeriya Lyssenko; Henrik Irgens; Ervin Fox; Frank Burslem; Stefan Johansson; M Julia Brosnan; Jeff K Trimmer; Christopher Newton-Cheh; Tiinamaija Tuomi; Anders Molven; James G Wilson; Christopher J O'Donnell; Sekar Kathiresan; Joel N Hirschhorn; Pål R Njølstad; Tim Rolph; J G Seidman; Stacey Gabriel; David R Cox; Christine E Seidman; Leif Groop; David Altshuler
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

5.  Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.

Authors:  Christopher Newton-Cheh; Martin G Larson; Ramachandran S Vasan; Daniel Levy; Kenneth D Bloch; Aarti Surti; Candace Guiducci; Sekar Kathiresan; Emelia J Benjamin; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Stefan Blankenberg; Frank Kee; Peter Nilsson; Xiaoyan Yin; Leena Peltonen; Erkki Vartiainen; Veikko Salomaa; Joel N Hirschhorn; Olle Melander; Thomas J Wang
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

6.  Marital status and occupation in relation to short-term case fatality after a first coronary event--a population based cohort.

Authors:  Sofia Gerward; Patrik Tydén; Gunnar Engström; Bo Hedblad
Journal:  BMC Public Health       Date:  2010-05-10       Impact factor: 3.295

7.  Long-term temporal trends in cardiovascular and metabolic risk factors.

Authors:  Wegene Borena; Tanja Stocks; Susanne Strohmaier; Alexander Strasak; Jonas Manjer; Dorthe Johansen; Håkan Jonsson; Kilian Rapp; Hans Concin; Göran Hallmans; Pär Stattin; Hanno Ulmer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

8.  A variant in the KCNQ1 gene predicts future type 2 diabetes and mediates impaired insulin secretion.

Authors:  Anna Jonsson; Bo Isomaa; Tiinamaija Tuomi; Jalal Taneera; Albert Salehi; Peter Nilsson; Leif Groop; Valeriya Lyssenko
Journal:  Diabetes       Date:  2009-07-07       Impact factor: 9.461

9.  Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project).

Authors:  Artur Fedorowski; Lars Stavenow; Bo Hedblad; Göran Berglund; Peter M Nilsson; Olle Melander
Journal:  Eur Heart J       Date:  2009-08-20       Impact factor: 29.983

10.  Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can).

Authors:  Tanja Stocks; Wegene Borena; Susanne Strohmaier; Tone Bjørge; Jonas Manjer; Anders Engeland; Dorthe Johansen; Randi Selmer; Göran Hallmans; Kilian Rapp; Hans Concin; Håkan Jonsson; Hanno Ulmer; Pär Stattin
Journal:  Int J Epidemiol       Date:  2009-04-20       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.